Cochlear Operating Income Over Time
| OC5 Stock | EUR 118.92 1.08 0.90% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Cochlear Performance and Cochlear Correlation. Cochlear |
Cross Equities Operating Income Analysis
Compare Cochlear Limited and related stocks such as Cerence, TELES Informationstech, and BIOTIME Operating Income Over Time
| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0S6 | 45.7 M | 45.7 M | 45.7 M | 45.7 M | 45.7 M | 45.7 M | 45.7 M | 45.7 M | 45.7 M | 38.9 M | 65.7 M | 38.3 M | (15.3 M) | 46.3 M | 13.1 M | 11.8 M | 11.2 M |
| TLIK | (597 K) | (597 K) | (597 K) | (597 K) | (597 K) | (597 K) | (597 K) | (329 K) | (2.1 M) | 4.8 M | (98.1 K) | (258.8 K) | (1.5 M) | (1.7 M) | (418.7 K) | (376.8 K) | (395.6 K) |
| BT3 | (59 M) | (59 M) | (59 M) | (59 M) | (59 M) | (59 M) | (59 M) | (40.7 M) | (41 M) | (38.9 M) | (26.4 M) | (49.2 M) | (22.5 M) | (24.7 M) | (21.5 M) | (24.7 M) | (25.9 M) |
| MS9 | 439.5 B | 439.5 B | 439.5 B | 439.5 B | 244.7 B | 69.4 B | (55.4 B) | 91.9 B | 29 B | 28.5 B | (9.6 B) | (48.4 B) | (183.3 B) | (214.7 B) | (70.8 B) | (63.7 B) | (60.5 B) |
| IB5A | (311.9 M) | (311.9 M) | (311.9 M) | (311.9 M) | (311.9 M) | (311.9 M) | (311.9 M) | (443.9 M) | (489.2 M) | (364.1 M) | (234.4 M) | (308.6 M) | (325.8 M) | (427.8 M) | (409.7 M) | (471.2 M) | (494.7 M) |
| MBJ | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (305.1 M) | (320.4 M) |
| MBJ | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (339 M) | (305.1 M) | (320.4 M) |
| TZO | (1.3 M) | (1.3 M) | (1.3 M) | (1.3 M) | (1 M) | (9.9 M) | (1.1 M) | (1.3 M) | (1 M) | (800.8 K) | (780.8 K) | (1.4 M) | (1.2 M) | (1.2 M) | (1.1 M) | (1.3 M) | (1.3 M) |
| AJW | (4.8 B) | (4.8 B) | (4.8 B) | (4.8 B) | (4.8 B) | (4.8 B) | (4.8 B) | (3.3 B) | (3.1 B) | (3.3 B) | (5.6 B) | (15.6 B) | (16.3 B) | (12 B) | (9.1 B) | (8.2 B) | (8.6 B) |
| 9R5 | (6.2 M) | (6.2 M) | (6.2 M) | (6.2 M) | (6.2 M) | (6.2 M) | (6.2 M) | (6.2 M) | (6.2 M) | (6.2 M) | (6.2 M) | (6.2 M) | (19.1 M) | (10.9 M) | (9.2 M) | (8.2 M) | (8.7 M) |
Cochlear Limited and related stocks such as Cerence, TELES Informationstech, and BIOTIME Operating Income description
Operating Income is the amount of profit realized from Cochlear Limited operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Cochlear Limited is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
| Cochlear Limited | OC5 |
Specialization | Health Care, Health Care Equipment & Services |
| Business Address | 1 University Avenue, |
| Exchange | Frankfurt Exchange |
EUR 118.92
Other Information on Investing in Cochlear Stock
Cochlear financial ratios help investors to determine whether Cochlear Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cochlear with respect to the benefits of owning Cochlear security.